Bavarian Nordic — December 2020
-
Zealand Pharma forspring på markedet for SBS: I finans.dk står der, at en konkurrent "Vectivbio" haler ind på Zealand og deres middel Glepaglutide, som følge af svær rekruttering under Covid. Men en konkurrent som Vectivbio der selv er færdig i fase 2, må alt andet lige også blive forsinket - hvordan skal de selv påbegynde en fase 3 når patienterne mangler = Zeal opretholder deres forspring. Nogle hol
dninger til dette? -
BAVA stiger 5% - hvad er nyheden?
-
Børsen har et skriv om de 3 aktier med størst potentiale i 2021 - Bava er en af dem
-
ok tak
-
velbe
-
Her Euroinvestors omtale af Børsens artikel https://www.euroinvestor.dk/nyheder/analytikerne-spaar-disse-
3-danske-aktier-stoerst-afkastpotentiale -
-
Og en fra 09.12, hvor Juul Value Invest anbefaler 3 aktier for 21: en cyklisk, en defensiv og en valgfri. Den defensive er BAVA.. https://www.euroinvestor.dk/nyheder/aktiechef-peger-paa-3-mulige-aktie-guldfugle-til-2021
-
Dasiglucagon on top of standard of care (SOC) did not significantly reduce the rate of hypoglycemia compared to SOC alone when assessed by intermittent self-measured plasma glucose (primary endpoint)
However, hypoglycemia was reduced by 40–50% with dasiglucagon as compared to SOC alone when assessed by blinded continuous glucose monitoring (exploratory analysis)
Dasiglucagon treatment was assessed to be safe and well tolerated in the study and 31 out of 32 patients continued into the -
We are disappointed this study did not meet the primary endpoint. However, we are encouraged by the meaningful reduction in hypoglycemic events observed with blinded CGM, and that all but one patient entered the long-term extension study,” stated Adam Steensberg, Chief Medical Officer at Zealand Pharma.
-
We remain committed to advancing dasiglucagon as a potential treatment of CHI due to the significant unmet medical need for these children, and will work closely with regulatory authorities to define the path forward while awaiting the outcome of the second phase 3 trial in younger children with CHI.”
-
Nogen holdning til det?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind